Minimizing Covid-19 deaths by accelerated vaccination strategies despite limited vaccine supply Kumar Jeetendra | August 3, 2021 Basel, Switzerland – 3rd August 2021 – Life Science Newswire – In the Covid-19 pandemic, new waves of Coronavirus “Variants of Concern” are currently observed in many countries and vaccination is one cornerstone of overcoming the pandemic. While many countries have chosen an “Elderly first, one dosage fits all” approach to vaccination, Swiss scientists have …
WHO calls for ban on COVID-19 vaccine booster dose Kumar Jeetendra | August 4, 2021 The World Health Organization is calling for a moratorium on COVID-19 vaccine boosters until at least the end of September, its head Tedros Adhanom Ghebreyesus said on Wednesday. The move was to enable that at least 10% of the population of every country was vaccinated, Tedros said. “I understand the concern of all governments to …
Delta variant of COVID-19 spreading quick in Sri Lanka Kumar Jeetendra | August 13, 2021 The highly transmissible Delta variant of the coronavirus is spreading rapidly across Sri Lanka and comprise around 75 per cent of the new cases reported in the Western province, experts said, warning that the island nation was facing its most decisive fortnight in its fight against the pandemic. There has been a rise in the …
New system joins PC programming and cryo-EM to decide 3D constructions of RNA-only molecules Kumar Jeetendra | August 16, 2021 The single-stranded gene material RNA, also known as RNA, is most well-known for its ability to guide the assembly of proteins and carry the genetic code for viruses such as HIV and SARS-CoV-2. Scientists discovered a hidden talent 40 years ago: It can catalyze chemical reaction in cells, including joining and snipping RNA strands. This …
Novel antibody candidate shows powerful binding to different SARS-CoV-2 variant mutations Kumar Jeetendra | September 25, 2021 Twist Bioscience Corporation today reported that its internally-discovered antibody candidate TB202-3 (CoVIC-094), demonstrated potent binding to diverse SARS-CoV-2 variant mutations, including strains with the E484K, N501Y, D614G, Y453F and K417N mutations in pseudovirus assays, indicating this therapeutic antibody may be effective in treating many strains of COVID-19. The Coronavirus Immunotherapy Consortium (CoVIC) is an academic-industry-non-profit …
New drug Molnupiravir can be the solution for our fight against COVID-19 Kumar Jeetendra | December 28, 2021 Mumbai, 28th December 2021: As countries prepare themselves to fight a possible ‘next wave’. The new variant – Omicron has been making headline and a surge in covid 19 cases are evident. According to a study based on population-level evidence, the recently identified Omicron variant of SARS-CoV-2 is associated with a substantial ability to evade …
New technique to make a modest and rapid COVID-19 test dependent on isothermal amplification Kumar Jeetendra | December 30, 2021 Russian researchers have devised the method to make an affordable and quick COVID-19 test that relies on isothermal amplifying. According to their paper in Applied Biochemistry and Microbiology The using this method can allow researchers to create universal test methods for any COVID-19 variations. There are many options for devices that detect the presence of SARS-CoV-2 within human …
Nano-bubbles containing ACE2 protein can hinder contamination from wide strains of SARS-CoV-2 Kumar Jeetendra | January 21, 2022 Northwestern Medicine and The University of Texas MD Anderson Cancer Center discovered that natural nano-bubbles containing ACE2 protein (evACE2) were found in the blood of COVID-19 victims. They also discovered that these particles could block infection by broad strains of SARS/CoV-2 virus. Scientists said that the evACE2 acts in the body as a decoy and …
